Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan

LIANG-CHUN SHIH, CHIA-WEN TSAI, WEN-SHIN CHANG, TE-CHUN SHEN, YUN-CHI WANG, JIA-SING YANG, MENG-LIANG LIN, ZHI-HONG WANG and DA-TIAN BAU
Anticancer Research October 2020, 40 (10) 5503-5508; DOI: https://doi.org/10.21873/anticanres.14562
LIANG-CHUN SHIH
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
2Department of Otorhinolaryngology, China Medical University Hospital, Taichung, Taiwan, R.O.C.
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIA-WEN TSAI
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEN-SHIN CHANG
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TE-CHUN SHEN
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUN-CHI WANG
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JIA-SING YANG
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
4Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MENG-LIANG LIN
5Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZHI-HONG WANG
6Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: datian{at}mail.cmuh.org.tw artbau2{at}gmail.com
DA-TIAN BAU
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
7Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: datian{at}mail.cmuh.org.tw artbau2{at}gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Accumulating evidence shows that caspase-8 (Cas-8) rs3834129 genotypes determine susceptibility to various cancers, but their association with nasopharyngeal carcinoma (NPC) has not been examined. We aimed at investigating the association of Cas-8 rs3834129 with NPC risk. Materials and Methods: Cas-8 rs3834129 genotypes and their associations with NPC risk were investigated among 176 NPC patients and 352 non-cancer subjects by the PCR-RFLP method. Additionally, the interaction of Cas-8 rs3834129 genotypes with smoking was examined. Results: The II, ID and DD frequencies were 56.8, 36.9 and 6.3% among NPC patients and 54.8, 38.1 and 7.1% among control subjects (ptrend=0.8830). Allelic frequency distribution analysis also indicated that the D allele is not a risk factor for NPC (p=0.6183). There was no interaction between Cas-8 rs3834129 and smoking and NPC risk (p=0.8305). Conclusion: Cas-8 rs3834129 genotypes play a minor role in the risk for NPC.

  • Case–control study
  • caspase-8
  • genotype
  • nasopharyngeal carcinoma
  • polymorphism
  • Taiwan

Nasopharyngeal carcinoma (NPC), or nasopharynx cancer, is a rapidly growing squamous cell carcinoma in nasopharynx which attacks both children and adults (1). Epidemiological studies have shown Epstein–Barr virus (EBV) infection to be a major risk factor for NPC and metastasis (2, 3). In addition, cigarette smoking and alcohol consumption have been also shown to serve as behavioral determiners of NPC risk (4, 5). In NPC-prevalent areas, every individual is exposed to similar environment factors, however, only a subpopulation may develop NPC, suggesting that genetic differences such as single-nucleotide polymorphisms (SNPs) may also contribute to NPC. The molecular mechanisms of NPC induced by these genetic factors are largely remaining unrevealed. The understanding of these genomic factors and how they contribute to NPC's etiology may help in providing novel biomarkers for early detection and prediction of NPC susceptibility and prognosis outcomes. For instance, mounting evidence indicates that the variant genotypes of genes involved in the production of inflammatory cytokines (6, 7), extracellular matrix metabolism (8), cell cycle regulation (9), and DNA repair capacity (10) could determine individual susceptibility to NPC.

Apoptosis is an essential mechanism, mediated by intrinsic and/or extrinsic pathways, triggered by cellular stress, DNA damage and immune surveillance, to alter cell morphology, and control the death rate in a stable population (11, 12). In the literature, mounting evidence indicates that the loss of homeostasis of the apoptotic pathway is associated with the development of cancer (13), while few FDA-approved anticancer agents are small molecules designed to inhibit anti-apoptotic BCL-2 family members (12).

Caspase-8 (Cas-8), one of the most important components of the caspase family, plays a critical role in the extrinsic apoptosis signaling (14, 15). Among the polymorphic sites at Cas-8, rs3834129 (-652, 6N insertion/deletion), a six-nucleotide insertion (I)/deletion (D) variant, has been functionally identified to down-regulate the levels of Cas-8 mRNA (16). There are at least 353 SNPs in Cas-8 reported in the NCBI dbSNP database. Cas-8 SNPs, such as D302H (rs1045485), IVS12-19G/A (rs3769818), and the promoter rs3834129 that will be the focus of the current study, have been reported to be potential genomic markers for the prediction of risk for several types of cancer such as neuroblastoma (17), breast cancer (18-20), lung cancer (21), digestive tract cancer (22, 23), prostate cancer (24), and bladder cancer (25). However, the role of Cas-8 polymorphisms in NPC is not known.

Based on the above, in the current study, we aimed at examining and evaluating the association of Cas-8 rs3834129 genotypes with NPC risk, as well as revealing the joint effects of Cas-8 rs3834129 genotypes with smoking behaviors on NPC risk in a representative Taiwanese population.

Materials and Methods

Study subjects. During the period of 2003 to 2009, 176 NPC patients were recruited in the department of general surgery outpatient clinics at the China Medical University Hospital. Clinically, the histological status and type of each NPC patient were identified and classified according to 1991 WHO classification system. For each case of NPC, two age-, gender- and behavior-matched cancer-free healthy subjects were manually selected among subjects of the regular health examination pool and included into the final comparison and evaluation. Thus, 352 healthy controls and 176 NPC patients were subjected to Cas-8 genotyping and final statistical analysis. All the protocols in the study were approved by the institutional review board of the China Medical University Hospital (DMR101-IRB1-306).

DNA preparation and storage. Genomic DNA was isolated from the peripheral blood leukocytes using the QIAamp Blood Mini Kit (Qiagen, Valencia, CA, USA), stored for long term at −80°C, diluted, and aliquoted for genotyping as a working stock at −20°C, as we have previously described (26, 27).

Cas-8 rs3834129 genotyping methodology. In brief, the polymerase chain reaction (PCR) cycling conditions were set as: 1) start with one cycle at 94°C for 5 min; 2) 35 cycles at 94°C for 30 s, 59°C for 30 s and 72°C for 30 s, 3) a final extension step at 72°C for 10 min. The self-designed sequences for Cas-8 rs3834129 genotyping primers were 5’-ACTCTGCATGCCAGGAGCTA-3’ and 5’-CTGGGGA AGCCTCACTGTAT-3’. After PCR amplification by a PCR Thermocycler (Bio-RAD, Hercules, CA, USA), the PCR products were digested with Pvu II (New England Biolabs, Beverly, MA, USA) and the products of the digestion were separated by 3% agarose gel electrophoresis. All the genotypic procedures were independently and blindly conducted by at least two well-experienced researchers. To confirm the PCR-RFLP results, 5% of the samples were randomly chosen and sent for direct sequencing. The results of direct sequencing and PCR-RFLP methodologies were 100% consistent to each other.

Statistical analysis. First, to make sure that the control subjects are representative of the Taiwan population, the deviations of the genotypic frequencies of Cas-8 rs3834129 of the control group from those expected under the Hardy–Weinberg equilibrium were assessed using the goodness-of-fit test. Second, the Pearson's chi-square test was used for examining the distributions of Cas-8 rs3834129 genotypes. Third, Student's t-test was used to examine the distribution of ages among the case and control groups. Last, the association between NPC risk and Cas-8 genotypes was estimated by calculating the odds ratios (ORs) and related 95% confidence intervals (CIs) in the logistic regression analysis, adjusted or unadjusted for potential confounders for NPC risk. Any p-value less than 0.05 was considered to be statistically significant.

Results

Comparisons of basic characteristics between the NPC and the control groups. The recorded information on age, gender, and personal behavioral habits of the investigated 176 NPC patients and the 352 non-cancer control subjects are summarized in Table I. As we matched the patients with controls by these indexes, no significant differences for age and gender between the case and control groups was observed (p>0.05). Also, no significant differences were observed between the case and control groups regarding personal behavioral habits, including cigarette smoking, alcohol drinking, and areca chewing consumption (all p>0.05) (Table I). The histological status for each NPC patient was identified and classified by experienced surgeons. There were 5 (2.8%) keratinizing squamous cell carcinoma (WHO type I) and 171 (97.2) non-keratinizing carcinoma (WHO type II) cases. Those type II NPC patients were further divided into 28 (15.9%) non-keratinizing differentiated carcinoma (WHO type IIa) and 143 (81.3%) non-keratinizing undifferentiated carcinoma (WHO type IIb) cases (Table I).

Association of Cas-8 promoter rs3834129 genotypes and NPC risk among Taiwanese. The distributions of Cas-8 rs3834129 genotypes among healthy controls and patients with NPC are presented in Table II. The distribution of Cas-8 rs3834129 genotypes in the control group fitted well with the Hardy-Weinberg Equilibrium (pHEW=0.7921). The genotypic percentages of Cas-8 rs3834129 were not differentially distributed among the NPC cases and the controls (p for trend=0.8830) (Table II). In detail, neither the heterozygous ID nor the homozygous DD genotype was associated with decreased NPC risk compared with the wild-type II genotype at Cas-8 rs3834129 (adjusted OR=0.93 and 0.86, 95%CI=0.68-1.31 and 0.56-1.83, p=0.7353 and 0.6686, respectively). In addition, the results of the dominant model of analysis showed that there was no significant association between ID+DD genotypes and NPC risk compared with II genotype at Cas-8 rs3834129 (adjusted OR=0.89, 95%CI=0.66-1.47, p=0.6647).

In order to validate the results in Table II, we performed the analysis of allelic frequency distributions for Cas-8 rs3834129 and the results are shown in Table III. Supporting the finding that Cas-8 rs3834129 genotypes are not associated with NPC risk, the variant allele D was also non-significantly associated with decreased NPC risk (adjusted OR=0.91, 95%CI=0.73-1.35, p=0.6183) (Table III).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Demographic characteristics of the 352 healthy controls and 176 NPC patients.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Distributions of Cas-8 rs3834129 genotypic frequencies among the NPC patients and healthy controls.

Interaction between Cas-8 rs3834129 genotypes and behavioral factors on NPC risk. From the epidemiological viewpoint, cigarette smoking, alcohol drinking and betel quid consumption may contribute to NPC in Taiwan. Therefore, we were interested in evaluating the interaction of Cas-8 rs3834129 genotypes with these personal behaviors among Taiwanese. First, among non-smokers, people with ID and DD genotypes at Cas-8 rs3834129 were at 1.01- and 0.83-fold odds ratio for NPC risk compared to those with the II genotype (95%CI=0.62-1.66 and 0.30-2.29, p=0.9681 and 0.7245) (Table IV, left panel). After adjusting for confounding factors including age, gender, alcohol drinking and betel quid chewing status, the statistical results still stayed at non-significant levels for ID and DD genotypes (Table IV, left panel). Meanwhile, similar non-significant associations were found among smokers (Table IV, right panel). The similar findings found among the subgroups of non-alcohol drinkers, alcohol drinkers, non-betel quid chewers, and betel quid chewers, showed that sub-groups of people with ID and DD genotypes at Cas-8 rs3834129 were not significantly different regarding the risk of having NPC compared with those with the II genotype (data not shown).

Discussion

Apoptosis plays critical roles in a wide variety of physiological and pathological processes during fetal development, adult maturation, and aging, while defects in the homeostatic regulation of apoptosis may contribute to human diseases, such as several types of cancer and autoimmune lymphoproliferative syndrome (ALPS) (28, 29). However, the knowledge of how genomic variants of caspases are involved in NPC etiology is still lacking. The Cas-8 gene encodes cysteine-aspartic acid protease 8, which plays a central role in the execution of programmed cell death (30). As originally identified, Cas-8 initiates apoptotic processes after being activated by various apoptotic stimuli, such as Fas and FADD, the Fas-interacting protein (31, 32). The activated Cas-8 may work alone or cooperate with other initiators, such as caspase-10, to activate the downstream executor caspases, such as caspase-3, to complete the apoptotic process (33). Among the SNPs on Cas-8, rs3834129 is the most commonly examined (34). In 2007, Sun and his colleagues firstly examined the contribution of Cas-8 rs3834129 polymorphism to the risk of many types of cancer (35). They obtained valuable pilot results indicating that the D allele at Cas-8 rs3834129 is associated with a decreased risk for some types of cancer including lung, colorectal, esophageal, breast, cervical and gastric cancer (35). After that, the genotypes of Cas-8 rs3834129 were found to be associated with the risk for melanoma (36), breast cancer (20), kidney cancer (37), and worse prognosis of neuroblastoma (17). Furthermore, the D allele at Cas-8 rs3834129 has been found to destroy the affinity of stimulatory protein 1 binding element for its promoter region, which results in a significantly decreased Cas-8 transcription and eventually a reduced apoptosis of T lymphocytes (35). However, the contribution of the Cas-8 rs3834129 genotypes to NPC risk had not been examined.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Allelic frequencies for Cas-8 rs3834129 polymorphisms among the NPC patients and healthy controls.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Odds ratios for association of Cas-8 rs3834129 genotype with NPC after stratification by personal smoking status.

In the current study, we firstly revealed that the ID or DD genotypes at Cas-8 rs3834129 were not significantly associated with NPC risk in a representative Taiwanese population containing 176 NPC patients and 352 control subjects (Tables II and III). In addition, after adjusting for the confounding factors, there was still no association between the Cas-8 rs3834129 genotypes with NPC risk. Furthermore, we analyzed the interaction of Cas-8 rs3834129 genotypes with several risk behaviors among Taiwanese including smoking, alcohol drinking, and betel quid chewing. The results indicated that there was no interaction among Cas-8 rs3834129 genotypes and cigarette smoking, alcohol drinking, or betel quid consumption on determining personal susceptibility for NPC (Table IV). We also examined the correlations between genotypes at Cas-8 rs3834129 and clinicopathological features of NPC patients. Gender, age and the pathological status of patients did not affect the influence of Cas-8 rs3834129 genotypes on NPC risk (data not shown). The finding in NPC was consistent with our previous study investigating the association of Cas-8 rs3834129 genotypes with oral cancer, another head and neck cancer (38). These highlight findings are also consistent with a previous report investigating the contribution of Cas-8 rs3834129 genotypes to oral cancer susceptibility in a South Indian population. Noticeably, Du and his colleagues have conducted a meta-analysis to investigate the association between the Cas-8 rs3834129 polymorphisms and the risk for digestive tract cancers (39). They found an evident association between Cas-8 rs3834129 polymorphisms and reduced digestive cancer risk, especially for Asians (22). Future studies investigating the association of Cas-8 rs3834129 polymorphism and the risk of NPC in larger and different populations are urgently required to confirm our findings. These results may contribute to revealing the influence of genomic factors among different ethnicities.

In conclusion, the study provided evidence showing that Cas-8 rs3834129 genotypes were not associated with altered risk for NPC in a representative Taiwanese population. In addition, in the stratified analyses, no interaction between Cas-8 rs3834129 and personal behaviors such as cigarette smoking, alcohol drinking, and betel quid consumption, on NPC risk determination was found.

Acknowledgements

The Authors appreciate the TissueBank of China Medical University Hospital for their excellent technical assistance and all the subjects, doctors, nurses and colleagues. The perfect technological expertise and efforts from Kai-Cheng Chan, Yu-Ting Chin, Tai-Lin Huang, Yu-Hsin Lin, Yi-Ru Huang and Yu-Chen Hsiau are also appreciated. This study was supported mainly by the China Medical University and Hospital (DMR-109-143) to Dr. Bau.

Footnotes

  • ↵* These Authors contributed equally to this study.

  • Authors' Contributions

    Research design: Shih LC, Tsai CW and Chang WS; patient and questionnaire summaries: Shih LC and Shen TC; experimental work: Wang YC and Yang JS; statistical analysis: Wang ZH and Lin ML; article writing: Wang ZH and Bau DT; review and revision: Chang WS, Tsai CW and Bau DT.

  • Conflicts of Interest

    The Authors declare no conflicts of interest in regard to this study.

  • Received July 27, 2020.
  • Revision received August 6, 2020.
  • Accepted August 7, 2020.
  • Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Lin CL,
    2. Lo WF,
    3. Lee TH,
    4. Ren Y,
    5. Hwang SL,
    6. Cheng YF,
    7. Chen CL,
    8. Chang YS,
    9. Lee SP,
    10. Rickinson AB,
    11. Tam PK
    : Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res 62(23): 6952-6958, 2002. PMID: 12460912.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. O'Neil JD,
    2. Owen TJ,
    3. Wood VHJ,
    4. Date KL,
    5. Valentine R,
    6. Chukwuma MB,
    7. Arrand JR,
    8. Dawson CW,
    9. Young LS
    : Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol 89(Pt 11): 2833-2842, 2008. PMID: 18931081. DOI: 10.1099/vir.0.2008/003392-0
    OpenUrlCrossRefPubMed
  3. ↵
    1. Yoshizaki T
    : Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol Histopathol 17(3): 845-850, 2002. PMID: 12168795. DOI: 10.14670/HH-17.845
    OpenUrlPubMed
  4. ↵
    1. Cheng YJ,
    2. Hildesheim A,
    3. Hsu MM,
    4. Chen IH,
    5. Brinton LA,
    6. Levine PH,
    7. Chen CJ,
    8. Yang CS
    : Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 10(3): 201-207, 1999. PMID: 10454065. DOI: 10.1023/a:1008893109257
    OpenUrlCrossRefPubMed
  5. ↵
    1. Long M,
    2. Fu Z,
    3. Li P,
    4. Nie Z
    : Cigarette smoking and the risk of nasopharyngeal carcinoma: a meta-analysis of epidemiological studies. BMJ Open 7(10): e016582, 2017. PMID: 28982817. DOI: 10.1136/bmjopen-2017-016582
    OpenUrlCrossRef
  6. ↵
    1. Huang CY,
    2. Chang WS,
    3. Tsai CW,
    4. Hsia TC,
    5. Shen TC,
    6. Bau DT,
    7. Shui HA
    : Interleukin-18 promoter genotype is associated with the risk of nasopharyngeal carcinoma in Taiwan. Cancer Manag Res 10: 5199-5207, 2018. PMID: 30464617. DOI: 10.2147/CMAR.S179367
    OpenUrl
  7. ↵
    1. Tsai CW,
    2. Tsai MH,
    3. Shih LC,
    4. Chang WS,
    5. Lin CC,
    6. Bau DT
    : Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan. Anticancer Res 33(8): 3391-3396, 2013. PMID: 23898109.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Tsai CW,
    2. Chang WS,
    3. Gong CL,
    4. Shih LC,
    5. Chen LY,
    6. Lin EY,
    7. Li HT,
    8. Yen ST,
    9. Wu CN,
    10. Bau DT
    : Contribution of matrix metallopeptidase-1 genotypes, smoking, alcohol drinking and areca chewing to nasopharyngeal carcinoma susceptibility. Anticancer Res 36(7): 3335-3340, 2016. PMID: 27354591.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Shih LC,
    2. Tsai CW,
    3. Tsai MH,
    4. Tsou YA,
    5. Chang WS,
    6. Li FJ,
    7. Lee MH,
    8. Bau DT
    : Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk. Anticancer Res 32(3): 1093-1098, 2012. PMID: 22399638.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Huang CY,
    2. Tsai CW,
    3. Hsu CM,
    4. Shih LC,
    5. Chang WS,
    6. Shui HA,
    7. Bau DT
    : The role of XRCC6/Ku70 in nasopharyngeal carcinoma. Int J Oral Maxillofac Surg 44(12): 1480-1485, 2015. PMID: 26149939. DOI: 10.1016/j.ijom.2015.06.008
    OpenUrlPubMed
  11. ↵
    1. Chen M,
    2. Wang J
    : Initiator caspases in apoptosis signaling pathways. Apoptosis 7(4): 313-319, 2002. PMID: 12101390. DOI: 10.1023/a:1016167228059
    OpenUrlCrossRefPubMed
  12. ↵
    1. Carneiro BA,
    2. El-Deiry WS
    : Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17(7): 395-417, 2020. PMID: 32203277. DOI: 10.1038/s41571-020-0341-y
    OpenUrl
  13. ↵
    1. Wang LH,
    2. Ting SC,
    3. Chen CH,
    4. Tsai CC,
    5. Lung O,
    6. Liu TC,
    7. Lee CW,
    8. Wang YY,
    9. Tsai CL,
    10. Lin YC
    : Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population. J Oral Pathol Med 39(2): 155-161, 2010. PMID: 20359312. DOI: 10.1111/j.1600-0714.2009.00873.x
    OpenUrlPubMed
  14. ↵
    1. Kuwana T,
    2. Smith JJ,
    3. Muzio M,
    4. Dixit V,
    5. Newmeyer DD,
    6. Kornbluth S
    : Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem 273(26): 16589-16594, 1998. PMID: 9632731. DOI: 10.1074/jbc.273.26.16589
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Yu J,
    2. Zhang L,
    3. Hwang PM,
    4. Kinzler KW,
    5. Vogelstein B
    : PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7(3): 673-682, 2001. PMID: 11463391. DOI: 10.1016/s1097-2765(01)00213-1
    OpenUrlCrossRefPubMed
  16. ↵
    1. Hashemi M,
    2. Eskandari-Nasab E,
    3. Fazaeli A,
    4. Rezaei H,
    5. Mashhadi MA,
    6. Arbabi F,
    7. Taheri M
    : Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene 505(1): 176-179, 2012. PMID: 22659694. DOI: 10.1016/j.gene.2012.05.043
    OpenUrl
  17. ↵
    1. Rihani A,
    2. De Wilde B,
    3. Zeka F,
    4. Laureys G,
    5. Francotte N,
    6. Tonini GP,
    7. Coco S,
    8. Versteeg R,
    9. Noguera R,
    10. Schulte JH,
    11. Eggert A,
    12. Stallings RL,
    13. Speleman F,
    14. Vandesompele J,
    15. Van Maerken T
    : CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients. PLoS One 9(12): e114696, 2014. PMID: 25502557. DOI: 10.1371/journal.pone.0114696
    OpenUrl
  18. ↵
    1. Kuhlmann JD,
    2. Bankfalvi A,
    3. Schmid KW,
    4. Callies R,
    5. Kimmig R,
    6. Wimberger P,
    7. Siffert W,
    8. Bachmann HS
    : Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer. BMC Cancer 16: 618, 2016. PMID: 27507139. DOI: 10.1186/s12885-016-2662-x
    OpenUrl
    1. Park HL,
    2. Ziogas A,
    3. Chang J,
    4. Desai B,
    5. Bessonova L,
    6. Garner C,
    7. Lee E,
    8. Neuhausen SL,
    9. Wang SS,
    10. Ma H,
    11. Clague J,
    12. Reynolds P,
    13. Lacey JV Jr..,
    14. Bernstein L,
    15. Anton-Culver H
    : Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer 16: 14, 2016. PMID: 26758508. DOI: 10.1186/s12885-015-2036-9
    OpenUrlCrossRef
  19. ↵
    1. Zhang Y,
    2. Li W,
    3. Hong Y,
    4. Wu G,
    5. He K,
    6. Liu D
    : A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk. J Genet 96(2): 283-289, 2017. PMID: 28674227. DOI: 10.1007/s12041-017-0774-y
    OpenUrl
  20. ↵
    1. Son JW,
    2. Kang HK,
    3. Chae MH,
    4. Choi JE,
    5. Park JM,
    6. Lee WK,
    7. Kim CH,
    8. Kim DS,
    9. Kam S,
    10. Kang YM,
    11. Park JY
    : Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 169(2): 121-127, 2006. PMID: 16938569. DOI: 10.1016/j.cancergencyto.2006.04.001
    OpenUrlCrossRefPubMed
  21. ↵
    1. Du H,
    2. Song GX,
    3. Fang MZ,
    4. Shu YQ,
    5. Zhao X,
    6. Zhu LJ
    : A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk. J Biomed Res 33(3): 173-180, 2019. PMID: 30057371. DOI: 10.7555/JBR.32.20160030
    OpenUrl
  22. ↵
    1. Wu Z,
    2. Li Y,
    3. Li S,
    4. Zhu L,
    5. Li G,
    6. Yu Z,
    7. Zhao X,
    8. Ge J,
    9. Cui B,
    10. Dong X,
    11. Tian S,
    12. Hu F,
    13. Zhao Y
    : Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer. Med Oncol 30(3): 565, 2013. PMID: 23715747. DOI: 10.1007/s12032-013-0565-0
    OpenUrl
  23. ↵
    1. Zhang CD,
    2. Li HT,
    3. Liu K,
    4. Lin ZD,
    5. Peng QL,
    6. Qin X,
    7. He M,
    8. Wu H,
    9. Mo ZN,
    10. Yang XL
    : Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups. Asian Pac J Cancer Prev 15(18): 7713-7718, 2014. PMID: 25292051. DOI: 10.7314/apjcp.2014.15.18.7713
    OpenUrlCrossRefPubMed
  24. ↵
    1. Srivastava K,
    2. Srivastava A,
    3. Mittal B
    : Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population. Mol Carcinog 49(7): 684-692, 2010. PMID: 20564345. DOI: 10.1002/mc.20641
    OpenUrlPubMed
  25. ↵
    1. Shih LC,
    2. Chang WS,
    3. Lee HT,
    4. Wang YC,
    5. Wang ZH,
    6. Chao CY,
    7. Yu CC,
    8. Lin HY,
    9. Shen TC,
    10. Kuo CC,
    11. Tsai CW,
    12. Bau DT
    : Interaction of interleukin-16 genotypes with betel quid chewing behavior on oral cancer in Taiwan. In Vivo 34(4): 1759-1764, 2020. PMID: 32606144. DOI: 10.21873/invivo.11969
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Li CH,
    2. Shih LC,
    3. Hsu CL,
    4. Lee HT,
    5. Wang YC,
    6. Chang WS,
    7. Tsai CW,
    8. Li CY,
    9. Bau DT
    : The contribution of interleukin-12A genotypes to oral cancer risk in Taiwanese. Anticancer Res 40(7): 3707-3712, 2020. PMID: 32620609. DOI: 10.21873/anticanres.14359
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Jackson CE,
    2. Puck JM
    : Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. Curr Opin Pediatr 11(6): 521-527, 1999. PMID: 10590910. DOI: 10.1097/00008480-199912000-00009
    OpenUrlCrossRefPubMed
  28. ↵
    1. Reed JC
    : Mechanisms of apoptosis. Am J Pathol 157: 1415-1430, 2000. PMID: 11073801. DOI: 10.1016/S0002-9440(10)64779-7
    OpenUrlCrossRefPubMed
  29. ↵
    1. Kruidering M,
    2. Evan GI
    : Caspase-8 in apoptosis: the beginning of “the end”? IUBMB Life 50(2): 85-90, 2000. PMID: 11185963. DOI: 10.1080/713803693
    OpenUrlCrossRefPubMed
  30. ↵
    1. Ghavami S,
    2. Hashemi M,
    3. Ande SR,
    4. Yeganeh B,
    5. Xiao W,
    6. Eshraghi M,
    7. Bus CJ,
    8. Kadkhoda K,
    9. Wiechec E,
    10. Halayko AJ,
    11. Los M
    : Apoptosis and cancer: mutations within caspase genes. J Med Genet 46(8): 497-510, 2009. PMID: 19505876. DOI: 10.1136/jmg.2009.066944
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Li J,
    2. Yuan J
    : Caspases in apoptosis and beyond. Oncogene 27(48): 6194-6206, 2008. PMID: 18931687. DOI: 10.1038/onc.2008.297
    OpenUrlCrossRefPubMed
  32. ↵
    1. Ashkenazi A
    : Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions. J Clin Invest 125(2): 487-489, 2015. PMID: 25642709. DOI: 10.1172/JCI80420
    OpenUrlCrossRefPubMed
  33. ↵
    1. Zhang F,
    2. Yang Y,
    3. Guo C,
    4. Wang Y
    : CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects. Mutagenesis 27(5): 559-566, 2012. PMID: 22513478. DOI: 10.1093/mutage/ges019
    OpenUrlCrossRefPubMed
  34. ↵
    1. Sun T,
    2. Gao Y,
    3. Tan W,
    4. Ma S,
    5. Shi Y,
    6. Yao J,
    7. Guo Y,
    8. Yang M,
    9. Zhang X,
    10. Zhang Q,
    11. Zeng C,
    12. Lin D
    : A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 39(5): 605-613, 2007. PMID: 17450141. DOI: 10.1038/ng2030
    OpenUrlCrossRefPubMed
  35. ↵
    1. Li C,
    2. Zhao H,
    3. Hu Z,
    4. Liu Z,
    5. Wang LE,
    6. Gershenwald JE,
    7. Prieto VG,
    8. Lee JE,
    9. Duvic M,
    10. Grimm EA,
    11. Wei Q
    : Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat 29(12): 1443-1451, 2008. PMID: 18563783. DOI: 10.1002/humu.20803
    OpenUrlCrossRefPubMed
  36. ↵
    1. de Martino M,
    2. Haitel A,
    3. Schatzl G,
    4. Klingler HC,
    5. Klatte T
    : The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis. J Urol 190(2): 717-722, 2013. PMID: 23313206. DOI: 10.1016/j.juro.2013.01.008
    OpenUrlPubMed
  37. ↵
    1. Shih LC,
    2. Tsai CW,
    3. Sun KT,
    4. Hsu HM,
    5. Shen TC,
    6. Tsai YT,
    7. Chang WS,
    8. Lin ML,
    9. Wang YC,
    10. Gong CL,
    11. Bau DT
    : Association of caspase-8 genotypes with oral cancer risk in Taiwan. In Vivo 33(4): 1151-1156, 2019. PMID: 31280204. DOI: 10.21873/invivo.11585
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Arunkumar G,
    2. Murugan AK,
    3. Nagarajan M,
    4. Ajay C,
    5. Rajaraman R,
    6. Munirajan AK
    : Absence of the frequently reported PIK3CA, CASP8, and NOTCH1 mutations in South Indian oral cancers. Oral Dis 23(5): 669-673, 2017. PMID: 28181739. DOI: 10.1111/odi.12655
    OpenUrl
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 10
October 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan
LIANG-CHUN SHIH, CHIA-WEN TSAI, WEN-SHIN CHANG, TE-CHUN SHEN, YUN-CHI WANG, JIA-SING YANG, MENG-LIANG LIN, ZHI-HONG WANG, DA-TIAN BAU
Anticancer Research Oct 2020, 40 (10) 5503-5508; DOI: 10.21873/anticanres.14562

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan
LIANG-CHUN SHIH, CHIA-WEN TSAI, WEN-SHIN CHANG, TE-CHUN SHEN, YUN-CHI WANG, JIA-SING YANG, MENG-LIANG LIN, ZHI-HONG WANG, DA-TIAN BAU
Anticancer Research Oct 2020, 40 (10) 5503-5508; DOI: 10.21873/anticanres.14562
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Association of Matrix Metalloproteinase-7 Genotypes With Nasopharyngeal Carcinoma Risk
  • Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk
  • Association of Matrix Metalloproteinase-9 Genotypes With Nasopharyngeal Carcinoma Risk
  • Significant Association of Cyclin D1 Promoter Genotypes With Asthma Susceptibility in Taiwan
  • Interaction of DNA Repair Gene XPC With Smoking and Betel Quid Chewing Behaviors of Oral Cancer
  • Significant Association of Chitinase 3-like 1 Genotypes to Asthma Risk in Taiwan
  • Google Scholar

More in this TOC Section

  • Integrative Analysis Combining Machine Learning and Functional Experiments Uncovers ISG15 As a Key Determinant of Cisplatin Resistance in Gastric Cancer
  • Allow Aloe to Do the Work: Aloe vera Constrains Growth of Bladder Cancer Cells and Modulates Expression of Key Costimulatory Molecules
  • PKF118-310 as a Potential Small Molecule Inhibitor Targeting the Wnt/β-Catenin Pathway for Gastric Cancer Therapy
Show more Experimental Studies

Keywords

  • case–control study
  • caspase-8
  • genotype
  • nasopharyngeal carcinoma
  • polymorphism
  • Taiwan
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire